Macquarie Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Macquarie Group’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-69,313	Closed	-$1.24M	–	2551
2017 Q4	$1.24M	Sell	69,313 -3,089	-4%	-$38K	﹤0.01%	1182
2017 Q3	$854K	Buy	72,402 +5,002	+7%	+$56.1K	﹤0.01%	1266
2017 Q2	$708K	Hold	67,400	–	–	﹤0.01%	1247
2017 Q1	$741K	Hold	67,400	–	–	﹤0.01%	1246
2016 Q4	$913K	Hold	67,400	–	–	﹤0.01%	1180
2016 Q3	$830K	Buy	67,400 +25,800	+62%	+$304K	﹤0.01%	1197
2016 Q2	$456K	Buy	+41,600	New	+$466K	﹤0.01%	1381

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Macquarie Group's SCMP Position: Q1 2018 in Review

Macquarie Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 69,313 shares — an estimated $1.24M sold.

Macquarie Group first reported a position in SCMP in Q2 2016 and held it in 7 quarters. The position peaked at $1.24M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Macquarie Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Macquarie Group sold 69,313 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.24M.
Macquarie Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2016 and held it in 7 quarters.
Macquarie Group's Sucampo Pharmaceuticals, Inc. position peaked at $1.24M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.